Pfizer Korea under fire over payment terms

Pharmaceutical giant Pfizer is accused of flexing its muscle by demanding more excessive payment terms, such as bank’s payment guarantee over bonds issued by hospitals, inviting criticism from domestic drug wholesaler.

The accusation comes at a time when Pfizer Korea has asked wholesalers to make cash payment.

With rising non-performing loans and deteriorating business conditions, Pfizer ...